Abstract
Candiduria is a common finding in hospitalized patients with indwelling urine-draining devices. Animal models for candiduria are not well-developed and, despite its prevalence and associated mortality, candiduria is understudied. The presence of Candida in urine does not imply disease because it is also a commensal. Biofilm formation on catheters and the host–pathogen interaction are likely to be important factors that contribute to the pathogenesis. The objective of this study was to establish a candiduria model in mice with indwelling catheters. Our data demonstrate that biofilm formation on indwelling catheters and persistent candiduria can be established in mice. The study supports the concept that biofilm formation contributes to persistence. It also outlines differences between catheter-related candiduria in mice and humans. Specifically, mice exhibit higher levels of leukocyturia. In addition, mean daily fungal burden in urine in the murine model is 10- to 100-fold lower than that in humans. These important findings must be taken into consideration when using this model to study host–pathogen interaction in the setting of candiduria.
Introduction
Candida albicans is the most common pathogen implicated in nosocomial urinary-tract infection (UTI). Studies report that 9–44 % of nosocomial UTIs are caused by Candida spp. (Passos et al., 2005; Richards et al., 1999, 2000). Clinical studies have consistently identified similar predisposing risk factors including old age, female sex, prior antibiotic usage and indwelling urine-draining devices (Alvarez-Lerma et al., 2003; Kauffman et al., 2000). Although the clinical significance of candiduria is disputed (Achkar & Fries, 2010), it is of concern that large studies in hospitalized and renal-transplant patients have reported reduced survival of candiduric patients compared with control populations (Alvarez-Lerma et al., 2003; Bougnoux et al., 2008; Safdar et al., 2005). Studies have reported that 8 % of candiduric patients developed candidaemia with the same species (Bougnoux et al., 2008).
Despite the high incidence of candiduria, only a few studies on its pathogenesis have been performed because adequate models are lacking. Reconstituted epithelial in vitro tissue models, cell lines as well as nematode models, do not mimic the host environment adequately (Means et al., 2009; Pukkila-Worley et al., 2009a, b).
So far, candiduria has been investigated predominantly in mice, rats and rabbits (Chen et al., 2006; Hurley & Winner, 1963; Khan & Owais, 2006; Navarro et al., 1994; Nishiksawa et al., 1997; Silva et al., 2007; Tarry et al., 1989; Toth & Hughes, 2006). Experiments in larger animals are more costly, cannot be done with large numbers and genetic-knockout strains are limited or do not exist. In addition, most published animal experiments examined renal candidiasis, which is achieved by intravenous injection of Candida. In that setting, haematogenous candidaemia leads to renal candidiasis, hence candiduria reflects a ‘descending’ infection.
However, molecular typing of Candida strains derived from vagina and urine has established a clonal relationship (Daniels et al., 2001; Silva et al., 2007) and supports the notion that candiduria similar to bacterial UTIs is mostly an ‘ascending’ infection and not the result of haematogenous invasion of the urinary-tract system. In hospitalized patients, ascending persistent candiduria in the setting of indwelling urine-draining devices is a very common entity, for which a murine model has not been established to date. The objective of this study was to determine whether a murine model for ascending persistent candiduria could be established and whether it would adequately mimic the pathogenesis of candiduria.
Methods
Candida strains.
C. albicans (strain SC5314) was obtained from the ATCC and kept in glycerol stocks at −70 °C. Thawed aliquots of strain SC5314 were streaked on Sabouraud dextrose agar (SDA) before growth in standard Sabouraud dextrose broth. Yeast cells were washed three times with sterile PBS prior to injection.
Mouse strains.
C57BL/6 and 129Sv mice (female, 6–8 weeks old) were purchased from the National Cancer Institute, Bethesda, MD, USA. The infection model was tested in lysozyme M-deficient (lysM−/−)mice because they exhibit increased sensitivity to pathogens. Lysozyme is present on mucosal surfaces and expressed by neutrophils and is an important effector in the defence barrier of innate immunity. These mice were a generous gift from Thomas Graf, Center for Genomic Regulation, Barcelona, Spain, and are described elsewhere (Faust et al., 2000). LysM−/− mice are transgenic mice that contain contributions from both C57BL/6 and 129Sv strains. Accordingly, the suggested control mice are the non-transgenic parental strains C57BL/6 and 129Sv. LysM−/− mice express GFP brightly in their phagocytic cells, including the neutrophils [polymorphonuclear neutrophils or white blood cells (WBCs)]. In all experiments, only female mice were used because the anatomy of the male urethra is prohibitive to catheterization. Infection, analgesia, anaesthesia and killing (by CO2) of mice were approved by and performed in accordance with the Animal Institute Committee at Albert Einstein College of Medicine.
Surgical placement of intravesicular catheter.
Mice were anaesthetized by intraperitoneal injection of ketamine (37.5 mg ml−1) and xylazine (1.9 mg ml−1). For catheter insertion, published procedures (Hopkins, 1999; Johnson & Lockatell, 1999) were modified and done under a surgical dissection microscope (10×) (Fig. 1a–c). Mice were placed in the supine position and a 5 mm suprapubic incision was done to expose the bladder. A 25 mm long polyethylene catheter threaded onto a guide wire was inserted via the urethra into bladder. The first part (4 mm) of the catheter was cut on the guide wire and released into the bladder lumen. Visualization of this 4 mm sling catheter segment through the translucent bladder wall was assisted by black catheter markings. To secure the catheter segment and prevent it from obstructing the bladder outlet, a 5-0 polypropylene suture was threaded through the lumen of the bladder catheter segment, back through the bladder wall, and a second bladder catheter was placed on the serosal side of the bladder, which prevents erosion of the suture. The abdomen was closed with sutures.
Fig. 1.

Murine model for catheter-associated candiduria. (a) Schematic of the secured indwelling catheter piece; (b) polyethelyne tube in the urethra; (c) open abdominal catheter with secured catheter.
Infection procedure.
Mice were infected 5–7 days after catheter placement. Histological analysis of bladder tissue was normal and leukocyturia was minimal prior to infection. Anaesthetized mice were infected intravesicularly by injection of yeast into the bladder via a polyethylene catheter, which was inserted as described above. The guide wire was removed and a 30G ½″ hypodermic needle attached to a 5–100 µl Hamilton syringe was inserted into the catheter opening. A 50 µl C. albicans cell suspension in sterile PBS was injected slowly into the bladder lumen. The size of the inoculum (containing 105–107 cells) was confirmed by plating diluted aliquots on SDA. The polyethylene tube was withdrawn and mice were returned to their cages. Sham-infected control mice were injected by the same procedure with PBS only.
Specimen collection and microscopic studies.
Urine was collected every third day over a period of 28 days into Eppendorf tubes by gently rubbing the suprapubic area of mice restrained in the supine position. WBCs and yeast cells were counted by haemocytometer, and 10 µl urine was added to 90 µl PBS and plated on SDA supplemented with streptomycin to determine fungal burden. Fungal burden (c.f.u.) varied among mice and also in consecutive collections from individual mice. Therefore, mean daily c.f.u. per mouse was calculated for the time period (28 days) and comparisons of mean daily counts were made between groups of mice (n = 5).
To assess whether dissemination occurred, fungal burden in spleen, bladder and one kidney was determined. Mice were killed with CO2 and organs were removed, homogenized in PBS and plated on SDA. Fungal burden (c.f.u.) was determined after incubation at 37 °C for 48 h and expressed as either c.f.u. ml−1 (for urine) or c.f.u. per total organ. For urine, the lower cut-off of detection was 100 c.f.u. (ml urine)−1, and for organs, it was 20 c.f.u. per total organ. For histological analysis, bladders were fixed in 10 % formalin, paraffin-embedded and sectioned at a thickness of 8 µm for histological study. Bladder tissue was stained by a standard haematoxylin and eosin staining protocol. To test for biofilm formation on indwelling catheters, scanning electron microscopy (SEM) was performed. Post-mortem, the catheter was removed from the bladder and placed in vials that contained cold (4 °C), buffered glutaraldehyde (2.5 %). The glutaraldehyde-fixed samples were then rinsed in 0.1 M cacodylate buffer [Na(CH3)2AsO2 . 3H2O], post-fixed in osmium tetroxide, rinsed again in cacodylate buffer and dehydrated in water/ethanol or ethanol/amyl acetate. Samples were critical point-dried, fixed to aluminium stubs, coated with gold–palladium and examined under a JEM U3 scanning electron microscope at 15–20 kV.
Statistical analysis.
Fungal burden data (c.f.u.) were converted into log10 units. Differences were calculated by t-test, Mann–Whitney and ANOVA, with PASWStatistics v. 18.0 (IBM) and Excel 2008 v. 12.2 (Microsoft).
Results
Model development
Impact of inoculum.
Different inocula (105–107) of C. albicans were tested to determine the number of yeast cells required to establish persistent infection. Fungal burden (c.f.u.) could only be documented in the urine of mice injected with an inoculum of 107 yeast cells delivered in a 50 µl volume of a yeast suspension of 2×108 ml−1 in PBS. Lower-dose inocula did not consistently result in persistent candiduria beyond 6 days. More concentrated yeast suspensions were too viscous to pass through the barrel of the syringe and higher volumes leaked out of the urethra.
Impact of mouse strain.
Infections were performed with LysM−/− mice and their control parent strains, C57BL/6 and 129Sv. LysM−/− mice allow easy distinction of yeast in urine from GFP-expressing WBCs. Mean daily fungal burden in 28 days was significantly higher in LysM−/− mice with an indwelling catheter than in their respective wild-type control mice, 129Sv and C57BL/6 (P<0.001; ANOVA). In mice without an indwelling catheter, mean daily fungal burden was significantly lower, and lowest in LysM−/− mice (P = 0.01; ANOVA) (Fig. 2a).
Fig. 2.
Urine fungal burden in mice with and without catheter. (a) Comparison of mean daily urine fungal burden (c.f.u. ml−1 in a 28 day period) of mice (n = 5 per group) with and without a catheter, infected intravesicularly with C. albicans. Error bars denote sd. *LysM−/− mice with an indwelling catheter exhibit significantly higher fungal burdens than mice without a catheter (P<0.001; t-test). **Significant differences were also seen in C57BL/6 mice (P = 0.01). (b) Mean fungal burden [log10(c.f.u.) ml−1] in urine over 28 days in groups of mice (n = 5) with or without indwelling catheter after infection with C. albicans. Mice initially have a higher fungal burden in urine that falls and then rises again after 15 days in mice with a catheter. Error bars denote sd.
Impact of indwelling catheter.
Persistent urinary fungal burdens were documented in mice with indwelling urinary catheters, whereas mice without indwelling urinary catheters barely sustained candiduria beyond detection level. Maximum fungal burden was documented early after infection and then had a downward trend over 2 weeks. In LysM−/− and C57BL/6 mice, c.f.u. in urine increased by 1–2 log10 after 15 days infection (Fig. 2b). On day 28, candiduria was still detectable in 75 % of LysM−/− and C57BL/6 mice, but in only 20 % of 129Sv mice with a catheter. In mice without an indwelling catheter, candiduria decreased and became undetectable in 93 % of control mice (14 of 15) by day 28. In six of nine mice with persistent candiduria, Candida was grown from bladder tissue, with fungal burden ranging from 2.0 to 4.5 log10(c.f.u.) per bladder (Fig. 2b). No yeast was grown from spleen or kidney. Yeast was not grown from organs of mice that did not have indwelling catheters.
Biofilm formation in vivo
It was apparent that fungal burden in urine increased again after 15 days, but only in catheterized LysM−/− and C57BL/6 mice. We examined nine catheters from both C57BL/6 control mice and LysM−/− mice that manifested persistent candiduria for 28 days. Biofilm formation occurred on all indwelling polyethylene tubes. Cells scratched off the polyethylene tubes were viable and grew on SDA (data not shown). SEM analysis of embedded catheters (removed on day 28) demonstrated thick biofilm formation on the outside and inside of the tubes. In vivo-generated biofilms were composed of yeast cells and hyphae that were adherent to the surfaces of the catheter (Fig. 3a–c).
Fig. 3.

SEM of biofilm formation on catheters. (a) Biofilm formation (double arrow) is present on the inside of the catheter (single arrow). Bar, 100 µm. (b) Biofilm (double arrow) on the outside of the catheter (single arrow). Bar, 200 µm. (c) Biofilm consists of a mesh of hyphae (single arrow), yeast cells and matrix adherent to the catheter (double arrow). Bar, 2 µm.
Inflammatory parameters in candiduric mice
Urinalysis demonstrated 1–5 WBCs per high-power field (400× magnification) in sham-infected mice, and in infected mice 5 days after they were operated on prior to infection. We did not find baseline differences in leukocyturia. Leukocyturia was higher than in humans, who commonly are asymptomatic and do not manifest leukocyturia (defined as >2×104 ml−1), in LysM−/− and C57BL/6 mice with indwelling catheters and persistent candiduria beyond 14 days infection. Early increases in leukocyturia may be a result of the infection procedure and were observed in most mice with and without catheters, but subsided (Fig. 4a), and a statistically significant increase in leukocyturia (P = 0.012 for day 7 versus days 14 and 21; Mann–Whitney) was observed in LysM−/− mice with persistent candiduria. The same trend was seen in C57BL/6 mice. Microscopic analysis of urine from LysM−/− mice, which express GFP in their WBCs, confirmed that counted leukocytes were fluorescent and not dead yeast cells (Fig. 4b). Histological analysis of bladder tissue (Fig. 4c–e) was performed on candiduric LysM−/− and C57BL/6 mice and showed chronic inflammation of submucosal bladder tissue. Large numbers of infiltrating lymphocytes, monocytes and eosinophils were detected. Chronic inflammation was detected both in mice with and in those without an indwelling catheter and did not appear different in C57BL/6 and LysM−/− mice (data not shown). No adherence to or invasion of mucosal membranes by Candida was seen.
Fig. 4.
Inflammatory response in mice with candiduria. (a) All three mouse strains (n = 5 mice per group) manifest more pronounced leukocyturia than humans and sham-infected mice. Significantly higher leukocyturia is observed in LysM−/− mice with an indwelling catheter at day 7 than at days 14* and 21** (P<0.012; Mann–Whitney). (b) Microscopic urinalysis in LysM−/− mice, which express GFP in WBCs, confirms that cells seen on the left in phase contrast are leukocytes and not dead yeast cells. Bar, 10 µm. (c) Non-inflamed bladder mucosa in a LysM−/− mouse that did not have an indwelling catheter placed and underwent sham infection 14 days previously. Bar, 30 µm. (d) Inflammation in submucosal bladder tissue of an infected LysM−/− mouse with indwelling catheter at 14 days after infection. Similar findings were seen in C57BL/6 mice with and without catheters. Bar, 30 µm. (e) Magnification (600×) of inflammatory cells in infected mice. Note that eosinophils, neutrophils and lymphocytes are detected.
Discussion
A model for persistent candiduria by ascending transurethral infection in mice with indwelling catheters was established. This model mimics the presentation of catheter-associated UTI in humans, where indwelling urine-draining devices constitute a major risk factor to develop persistent candiduria (Kauffman et al., 2000). The model cannot be established in male mice, but candiduria predominantly occurs in elderly female patients (Kauffman, 2005).
The only trauma to the bladder consists of two punctures when suturing the catheter to the bladder wall (Hopkins, 1999; Johnson & Lockatell, 1999). This prevents urethral or ureteral obstruction. Candida biofilms form in the lumen of the catheter. As a consequence, the tube does not drain the urine from the bladder lumen as draining devices in patients do. The foreign body in this model is polyethylene tubing with luminal and external surfaces similar to those of urinary catheters. Latex, the material of which most urine-draining devices are made, is not available in small lumen sizes. Although biofilm formation varies on different plastic surfaces and may be dependent on growth conditions (Hawser & Douglas, 1994; Jain et al., 2007), SEM analysis of indwelling catheters established that thick biofilms are formed in vivo on the indwelling tube. C. albicans biofilms are investigated here because they are resistant to antifungals (Blankenship & Mitchell, 2006; Chandra et al., 2001; Hasan et al., 2009; Kauffman et al., 2000; Pierce et al., 2008) and interfere with successful treatment in patients. Furthermore, in vitro biofilm formation of clinical C. albicans strains is highly variable and may be associated with higher potential to cause disease (Hasan et al., 2009; Jain et al., 2007; Shin et al., 2002). This model provides a means to study such clinically relevant hypotheses systematically in vivo. Of note is that retrograde ascent of C. albicans cannot be studied in standard mice because they are not colonized by C. albicans. This could, however, be achieved with 17β-oestradiol injections (Fidel et al., 1999) and/or gnotobiotic mice, which can be colonized from birth (Balish et al., 1990).
We demonstrate that persistent low-level candiduria in mice required a high inoculum of yeast and the presence of an indwelling catheter. Others have also reported requirement of high inocula (5×106) for Escherichia coli and, even there, significant variability of urine bacterial burden, ranging from 102 to 107 c.f.u., was reported after 72 h (Jakobsen et al., 2010). It is noteworthy that other commonly investigated infection models, e.g. with the highly virulent human pathogen Staphylococcus aureus, also require high inocula and the bacteria are still cleared rapidly (Yao et al., 1997). In mice without an indwelling catheter, funguria was documented mostly around the level of detection, but the level of urine fungal burden rose and stayed above the NIH-defined threshold for candiduria [103 c.f.u. (ml urine)−1; Kauffman et al., 2000] in mice with catheters. Based on our results, it is advisable not to rely on one time point, but rather to measure persistent candiduria in urine over time, as day-to-day variation is present, but trends are stable. Most patients with candiduria have fungal burdens between 5 and 6 log10(c.f.u.) (Jain et al., 2007). They mostly have urine-draining devices in place, removal of which can result in spontaneous resolution of candiduria (Kauffman et al., 2000). In a non-catheter-associated murine UTI model, others (Domergue et al., 2005) have reported higher fungal burdens [3–4 log10(c.f.u.) in mice] in bladder and also in kidney. These studies were done with Candida glabrata and cultures were obtained only early after infection (days 4 and 7) from bladder and kidney, and not from urine.
Our studies indicate that some mouse strains, such as 129Sv, may be less susceptible than C57BL/6 mice. C57BL/6 mice are the standard parent strain of knockout mice, which allows a systematic approach to studying the contribution of individual host genes to the pathogenesis of candiduria. In contrast to oropharyngeal candidiasis, candiduria is not diagnosed predominantly in patients with deficiencies in T-cell-mediated immunity, but occurs more often in elderly patients. Thus, commercially available colonies of old C57BL/6 mice could be used to study the contribution of age and the resulting altered immunity to host–pathogen interaction.
In vitro lysozyme inhibits Candida and has been proposed to be a relevant effector molecule against Candida overgrowth in the oral cavity (Hibino et al., 2009; Lee et al., 2010; Samaranayake et al., 1993, 2009). Although increased susceptibility of LysM−/− mice to Micrococcus luteus and other pathogens has been reported (Ganz et al., 2003; Markart et al., 2004; Shimada et al., 2008), LysM−/− mice are only mildly immunosuppressed and hence it was reasonable to test whether they constitute a good mouse strain to establish candiduria. In addition, the fluorescent WBCs allow easy differentiation of yeast and WBCs in urine. Our observation that these mice exhibit higher leukocyturia is consistent with observations from other infection models, which have shown enhanced inflammation. At the time of our study, the LysM−/− mice were not entirely back-crossed to the C57BL/6 mice, which limited our ability to draw definitive conclusions on the importance of lysozyme as an effector molecule. Other LysM−/− mice have also been cloned (Sinha et al., 2004) and could potentially be used in future experiments.
Significant leukocyturia (defined as >20 WBCs µl−1) (Stamm, 1983) is absent in most candiduric patients (Kauffman et al., 2000) and this would have to be taken into account when analysing the host response in mice. Histological analysis of bladders demonstrated that Candida did not adhere to or invade the bladder surface and is in accordance with rat experiments that report lack of adherence of Candida to bladder mucosa (Levison & Pitsakis, 1987). The level of invasion and extent of bladder inflammation in human Candida infection have not been studied systematically; mostly extreme cases of emphysematous candidiasis have been reported (Bartkowski & Lanesky, 1988; Comiter et al., 1996).
In summary, we describe a murine model for catheter-associated candiduria that is suited to investigations of the pathogenesis of candiduria, including the role of in vivo biofilm formation and its contribution to persistence. Mice mount a pronounced inflammatory response to Candida spp. that may limit the fungal burden. In that respect, even the ascending catheter model will have some limitations in deciphering the pathogenesis of candiduria.
Acknowledgements
We thank Emily Cook and Neena Jain for technical help. This work was funded by NIH grants AI059681-05, R21AI087564-01 and T32 AI 07506 to X. W. and in part by pilot funds from the Einstein–Montefiore Center for AIDS (NIH AI-51519).
Abbreviations:
- SDA
Sabouraud dextrose agar
- SEM
scanning electron microscopy
- UTI
urinary-tract infection
- WBC
white blood cell
References
- Achkar J. M., Fries B. C. (2010). Candida infections of the genitourinary tract. Clin Microbiol Rev 23, 253–273 10.1128/CMR.00076-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alvarez-Lerma F., Nolla-Salas J., León C., Palomar M., Jordá R., Carrasco N., Bobillo F., EPCAN Study Group (2003). Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med 29, 1069–1076 10.1007/s00134-003-1807-y [DOI] [PubMed] [Google Scholar]
- Balish E., Filutowicz H., Oberley T. D. (1990). Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect Immun 58, 107–113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bartkowski D. P., Lanesky J. R. (1988). Emphysematous prostatitis and cystitis secondary to Candida albicans. J Urol 139, 1063–1065 [DOI] [PubMed] [Google Scholar]
- Blankenship J. R., Mitchell A. P. (2006). How to build a biofilm: a fungal perspective. Curr Opin Microbiol 9, 588–594 10.1016/j.mib.2006.10.003 [DOI] [PubMed] [Google Scholar]
- Bougnoux M. E., Kac G., Aegerter P., d’Enfert C., Fagon J. Y., CandiRea Study Group (2008). Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 34, 292–299 10.1007/s00134-007-0865-y [DOI] [PubMed] [Google Scholar]
- Chandra J., Kuhn D. M., Mukherjee P. K., Hoyer L. L., McCormick T., Ghannoum M. A. (2001). Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183, 5385–5394 10.1128/JB.183.18.5385-5394.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen C. G., Yang Y. L., Cheng H. H., Su C. L., Huang S. F., Chen C. T., Liu Y. T., Su I. J., Lo H. J. (2006). Non-lethal Candida albicans cph1/cph1 efg1/efg1 transcription factor mutant establishing restricted zone of infection in a mouse model of systemic infection. Int J Immunopathol Pharmacol 19, 561–565 [DOI] [PubMed] [Google Scholar]
- Comiter C. V., McDonald M., Minton J., Yalla S. V. (1996). Fungal bezoar and bladder rupture secondary to Candida tropicalis. Urology 47, 439–441 10.1016/S0090-4295(99)80470-1 [DOI] [PubMed] [Google Scholar]
- Daniels W., Glover D. D., Essmann M., Larsen B. (2001). Candidiasis during pregnancy may result from isogenic commensal strains. Infect Dis Obstet Gynecol 9, 65–73 10.1155/S1064744901000138 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Domergue R., Castaño I., De Las Peñas A., Zupancic M., Lockatell V., Hebel J. R., Johnson D., Cormack B. P. (2005). Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 308, 866–870 10.1126/science.1108640 [DOI] [PubMed] [Google Scholar]
- Faust N., Varas F., Kelly L. M., Heck S., Graf T. (2000). Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood 96, 719–726 [PubMed] [Google Scholar]
- Fidel P. L., Jr, Luo W., Steele C., Chabain J., Baker M., Wormley F., Jr (1999). Analysis of vaginal cell populations during experimental vaginal candidiasis. Infect Immun 67, 3135–3140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ganz T., Gabayan V., Liao H. I., Liu L., Oren A., Graf T., Cole A. M. (2003). Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan. Blood 101, 2388–2392 10.1182/blood-2002-07-2319 [DOI] [PubMed] [Google Scholar]
- Hasan F., Xess I., Wang X., Jain N., Fries B. C. (2009). Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect 11, 753–761 10.1016/j.micinf.2009.04.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hawser S. P., Douglas L. J. (1994). Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62, 915–921 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hibino K., Samaranayake L. P., Hägg U., Wong R. W., Lee W. (2009). The role of salivary factors in persistent oral carriage of Candida in humans. Arch Oral Biol 54, 678–683 10.1016/j.archoralbio.2009.04.003 [DOI] [PubMed] [Google Scholar]
- Hopkins W. J. (1999). Mouse model of ascending urinary tract infection. In Handbook of Animal Models of Infection: Experimental Models in Antimicrobial Chemotherapy, pp. 435–441 Edited by Zak O., Sande M. A. San Diego, CA: Academic Press; 10.1016/B978-012775390-4/50189-5 [DOI] [Google Scholar]
- Hurley R., Winner H. I. (1963). Experimental renal moniliasis in the mouse. J Pathol Bacteriol 86, 75–82 10.1002/path.1700860109 [DOI] [PubMed] [Google Scholar]
- Jain N., Kohli R., Cook E., Gialanella P., Chang T., Fries B. C. (2007). Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol 73, 1697–1703 10.1128/AEM.02439-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jakobsen L., Hammerum A. M., Frimodt-Møller N. (2010). Virulence of Escherichia coli B2 isolates from meat and animals in a murine model of ascending urinary tract infection (UTI): evidence that UTI is a zoonosis. J Clin Microbiol 48, 2978–2980 10.1128/JCM.00281-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson D. E., Lockatell C. V. (1999). Mouse model of ascending UTI involving short and long-term indwelling catheters. In Handbook of Animal Models of Infection: Experimental Models in Antimicrobial Chemotherapy, pp. 441–445 Edited by Zak O., Sande M. A. San Diego, CA: Academic Press; 10.1016/B978-012775390-4/50190-1 [DOI] [Google Scholar]
- Kauffman C. A. (2005). Candiduria. Clin Infect Dis 41 (Suppl. 6)S371–S376 10.1086/430918 [DOI] [PubMed] [Google Scholar]
- Kauffman C. A., Vazquez J. A., Sobel J. D., Gallis H. A., McKinsey D. S., Karchmer A. W., Sugar A. M., Sharkey P. K., Wise G. J., et al. (2000). Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis 30, 14–18 10.1086/313583 [DOI] [PubMed] [Google Scholar]
- Khan M. A., Owais M. (2006). Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model. J Antimicrob Chemother 58, 125–132 10.1093/jac/dkl177 [DOI] [PubMed] [Google Scholar]
- Lee J. Y., Kim Y. Y., Chang J. Y., Park M. S., Kho H. S. (2010). The effects of peroxidase on the enzymatic and candidacidal activities of lysozyme. Arch Oral Biol 55, 607–612 10.1016/j.archoralbio.2010.06.001 [DOI] [PubMed] [Google Scholar]
- Levison M. E., Pitsakis P. G. (1987). Susceptibility to experimental Candida albicans urinary tract infection in the rat. J Infect Dis 155, 841–846 10.1093/infdis/155.5.841 [DOI] [PubMed] [Google Scholar]
- Markart P., Korfhagen T. R., Weaver T. E., Akinbi H. T. (2004). Mouse lysozyme M is important in pulmonary host defense against Klebsiella pneumoniae infection. Am J Respir Crit Care Med 169, 454–458 10.1164/rccm.200305-669OC [DOI] [PubMed] [Google Scholar]
- Means T. K., Mylonakis E., Tampakakis E., Colvin R. A., Seung E., Puckett L., Tai M. F., Stewart C. R., Pukkila-Worley R., et al. (2009). Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med 206, 637–653 10.1084/jem.20082109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Navarro E. E., Almario J. S., King C., Bacher J., Pizzo P. A., Walsh T. J. (1994). Detection of Candida casts in experimental renal candidiasis: implications for the diagnosis and pathogenesis of upper urinary tract infection. J Med Vet Mycol 32, 415–426 10.1080/02681219480000571 [DOI] [PubMed] [Google Scholar]
- Nishiksawa T., Tokunaga S., Fuse F., Takashima M., Noda T., Ohkawa M., Nakamura S., Namiki M. (1997). Experimental study of ascending Candida albicans pyelonephritis focusing on the hyphal form and oxidant injury. Urol Int 58, 131–136 10.1159/000282969 [DOI] [PubMed] [Google Scholar]
- Passos X. S., Sales W. S., Maciel P. J., Costa C. R., Miranda K. C., Lemos J. de A., Batista M. de A., Silva M. do R. R. (2005). Candida colonization in intensive care unit patients’ urine. Mem Inst Oswaldo Cruz 100, 925–928 10.1590/S0074-02762005000800016 [DOI] [PubMed] [Google Scholar]
- Pierce C. G., Uppuluri P., Tristan A. R., Wormley F. L., Jr, Mowat E., Ramage G., Lopez-Ribot J. L. (2008). A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 3, 1494–1500 10.1038/nport.2008.141 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pukkila-Worley R., Holson E., Wagner F., Mylonakis E. (2009a). Antifungal drug discovery through the study of invertebrate model hosts. Curr Med Chem 16, 1588–1595 10.2174/092986709788186237 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pukkila-Worley R., Peleg A. Y., Tampakakis E., Mylonakis E. (2009b). Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell 8, 1750–1758 10.1128/EC.00163-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Richards M. J., Edwards J. R., Culver D. H., Gaynes R. P., National Nosocomial Infections Surveillance System (1999). Nosocomial infections in pediatric intensive care units in the United States. Pediatrics 103, e39 10.1542/peds.103.4.e39 [DOI] [PubMed] [Google Scholar]
- Richards M. J., Edwards J. R., Culver D. H., Gaynes R. P. (2000). Nosocomial infections in combined medical–surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21, 510–515 10.1086/501795 [DOI] [PubMed] [Google Scholar]
- Safdar N., Slattery W. R., Knasinski V., Gangnon R. E., Li Z., Pirsch J. D., Andes D. (2005). Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis 40, 1413–1421 10.1086/429620 [DOI] [PubMed] [Google Scholar]
- Samaranayake Y. H., MacFarlane T. W., Aitchison T. C., Samaranayake L. P. (1993). The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media. Oral Microbiol Immunol 8, 177–181 10.1111/j.1399-302X.1993.tb00662.x [DOI] [PubMed] [Google Scholar]
- Samaranayake Y. H., Cheung B. P., Parahitiyawa N., Seneviratne C. J., Yau J. Y., Yeung K. W., Samaranayake L. P. (2009). Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces. Arch Oral Biol 54, 115–126 10.1016/j.archoralbio.2008.09.015 [DOI] [PubMed] [Google Scholar]
- Shimada J., Moon S. K., Lee H. Y., Takeshita T., Pan H., Woo J. I., Gellibolian R., Yamanaka N., Lim D. J. (2008). Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis media. BMC Infect Dis 8, 134 10.1186/1471-2334-8-134 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shin J. H., Kee S. J., Shin M. G., Kim S. H., Shin D. H., Lee S. K., Suh S. P., Ryang D. W. (2002). Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40, 1244–1248 10.1128/JCM.40.4.1244-1248.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silva V., Hermosilla G., Abarca C. (2007). Nosocomial candiduria in women undergoing urinary catheterization. Clonal relationship between strains isolated from vaginal tract and urine. Med Mycol 45, 645–651 10.1080/13693780701601736 [DOI] [PubMed] [Google Scholar]
- Sinha P., Chi H. H., Kim H. R., Clausen B. E., Pederson B., Sercarz E. E., Forster I., Moudgil K. D. (2004). Mouse lysozyme-M knockout mice reveal how the self-determinant hierarchy shapes the T cell repertoire against this circulating self antigen in wild-type mice. J Immunol 173, 1763–1771 [DOI] [PubMed] [Google Scholar]
- Stamm W. E. (1983). Measurement of pyuria and its relation to bacteriuria. Am J Med 75 (1B)53–58 10.1016/0002-9343(83)90073-6 [DOI] [PubMed] [Google Scholar]
- Tarry W. F., Kowalkowski T. S., Fisher M. A. (1989). Renal candidiasis in the rat: effects of ureteral obstruction and diabetes. Urol Res 17, 367–370 10.1007/BF00510528 [DOI] [PubMed] [Google Scholar]
- Toth L. A., Hughes L. F. (2006). Sleep and temperature responses of inbred mice with Candida albicans-induced pyelonephritis. Comp Med 56, 252–261 [PubMed] [Google Scholar]
- Yao L., Berman J. W., Factor S. M., Lowy F. D. (1997). Correlation of histopathologic and bacteriologic changes with cytokine expression in an experimental murine model of bacteremic Staphylococcus aureus infection. Infect Immun 65, 3889–3895 [DOI] [PMC free article] [PubMed] [Google Scholar]


